期刊文献+

全身炎症反应综合征患者血清补体和抗凝血酶Ⅲ血浆D-二聚体的变化 被引量:2

Change of C_3 and C_4,AT-Ⅲ in serum and D-dimer quantity in plasma with SIRS
下载PDF
导出
摘要 目的 探讨全身炎症反应综合征 (SIRS)患者血清补体 (C3 、C4)、AT -Ⅲ及血浆D -二聚体 (D -dimer)含量变化及其与SIRS病情严重程度和预后的关系。方法 用全自动免疫比浊定量分析法和酶联免疫吸附 (ELISA)法对 97例SIRS及32例非SIRS患者和 30例健康体检者血清补体C3 、C4、AT -Ⅲ及血浆D -dimer含量进行测定 ,并对SIRS患者不同住院时间的血清补体C3 、C4、AT -Ⅲ及血浆D -dimer含量进行测定。结果 SIRS组C3 、C4、AT -Ⅲ水平明显下降 ,D -dimer含量显著升高 ,与对照组和非SIRS组比较存在显著差异 (C3 、AT -Ⅲ、D -dimer:P均 <0 0 1,C4:P <0 0 5 ) ;SIRS组中病情好转者上述各指标随时间推移渐趋正常 ,至发生SIRS后第 7日上述各指标与正常对照组比较无明显差异 (P均 >0 0 5 ) ,而恶化组C3 、C4及AT-Ⅲ继续下降 ,D -dimer则进一步上升 ,与正常对照组比较存在显著差异 (P均 <0 0 1)。结论 SIRS患者存在血清补体 (C3 、C4)、AT -Ⅲ含量下降和血浆D -dimer含量升高 ,它们的变化与病情严重程度和预后相关。 ObjectiveTo investigate the clinical significance of changes in complement system and coagulation system in the patients with SIRS.Methods97 patients with SIRS were divided into non-infection-SIRS,sepsis,severe sepsis and sepsis shock group.The levels of C 3,C 4 and AT-Ⅲ were measured by photometry immune-turbidimetric test with automated biochemical analysis and the results were expressed as g/L,while the quantity of D-dimer was measured by enzyme linked immunosorbent assay.ResultsC 3,C 4 and AT-Ⅲ decreased but D-dimer markedly increased in SIRS group (C 3,AT-Ⅲ,D-dimer:all P<0.01.C 4:P<0.05);C 3,C 4,AT-Ⅲ and D-dimer returned to normal range in improvement group of SIRS on the 7th day after SIRS (all P<0.01).ConclusionC 3,C 4 and AT-Ⅲ decreased but D-dimer markedly increased in the patients with SIRS, which would be one of the useful indexes for judging the course and prognosis of patients with SIRS.
出处 《中国急救医学》 CAS CSCD 北大核心 2003年第12期847-849,共3页 Chinese Journal of Critical Care Medicine
关键词 全身炎症反应综合征 血清补体 抗凝血酶 AT—Ⅲ 血浆D—二聚体 Systemic inflammatory response syndrome Complement Antithrombin Ⅲ D-dimer
  • 相关文献

参考文献3

二级参考文献1

共引文献96

同被引文献24

  • 1潘景业,王明山,王均炉,徐斐,金艳慧.危重患者抗凝血酶与纤溶功能的动态变化[J].中华麻醉学杂志,2005,25(4):295-297. 被引量:6
  • 2单小鸥,何时军,钱彩,王传夏,周爱华.C反应蛋白在预测细菌感染中的作用[J].中华急诊医学杂志,2007,16(3):295-298. 被引量:31
  • 3董广涛,王秀洁,王明轩,郭利莉.载脂蛋白AⅠ、C-反应蛋白和白蛋白与全身炎症反应综合征预后的关系[J].中华急诊医学杂志,2007,16(4):418-420. 被引量:7
  • 4Levy MM, Fink MP, Marshall JC, et al. 200l SCCM/ESICM/ ACCP/ATS/SIS international sepsis definitions conference. Crit Care Med, 2003, 31 : 1250-1256.
  • 5Opal SM. Clinical trial design and outcomes in patients with severe sepsis. Shock, 2003, 20: 295-302.
  • 6Lglarz M, Silvestre JS, Dufiez M, et al. Chronic blockade of endo- thelin receptors improves ischemia-induced angiogenesis in" rat hindlimbs through activation of vascular endothelial growth factor- no pathway[J]. Arteriescler Thromb Vasc Biol, 2001,21 (10) : 1598-1602.
  • 7Marik PE, Zalaga GP. Adrenal insurfficiency in the critical ill: a new look at an old problem [ J ]. Chest, 2002, 122 (5) : 1784- 1796.
  • 8Robinson LE, van Soeren MH. Insulin resistence and hyperglyce- mia in critical illness: role of insulin in glyeemic control [ J ]. AACb/ Clin Issues, 2004,15( 1 ) :45-62.
  • 9Bick RL, Baker WF. Diagnostic efficacy of the D-dimer assay in disseminated intravascular coagulation ( DIC ) [ J ]. Thromb Res, 1992,65 (6) :785-789.
  • 10Rey C, Los Arcos M, Concha A, et al. Procalcitonin and C-reac- tive protein as markers systemic inflammatory response syndrome severity in critically ill children[ J]. Intensive Care Med, 2007,33 ( 3 ) :477-482.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部